Trial Profile
A retrospective, single-centre, observational study to evaluate safety and efficacy of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Acenocoumarol
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 22 Aug 2017 New trial record